Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

carboxyphenyl retinamide

A synthetic phenylretinamide analogue of retinol (vitamin A) with potential antineoplastic and chemopreventive activities. Carboxyphenyl retinamide induces cell differentiation and inhibits tumor cell growth and carcinogenesis. This agent may also induce cell cycle arrest in the G1 phase in some cancer cell types.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	RII
Chemical structure:	4-carboxyphenyl retinamide N-(4-carboxyphenyl)retinamide

carboxyphenyl retinamide

Search NCI's Drug Dictionary